Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
110 |
|
| Actual shortage: | 19 (17%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 89 (81%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 3 (33%) | |
| Discontinued: | 6 (67%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (13%) |
|
Overdue reports |
15 (65%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2017-12-22 | 2018-02-15 | 34258 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2018-03-08 | 2018-05-16 | 42273 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2018-02-15 | 2018-03-10 | 39953 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Actual shortage | 2021-05-14 | 2021-05-15 | 139438 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 0.01MG 20MG | SOLUTION | Resolved | 2022-04-14 | 2023-02-21 | 158881 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-04-14 | 2022-09-08 | 158884 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-03-06 | 207616 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-10-20 | 2024-04-09 | 207619 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Actual shortage | 2025-02-24 | 2025-11-26 | 251173 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2025-03-04 | 2025-05-02 | 251897 |
| METHYLENE BLUE INJECTION USP | 10MG | SOLUTION | Actual shortage | 2018-04-04 | 2018-04-04 | 44896 |
| MICAFUNGIN SODIUM FOR INJECTION | 50MG | POWDER FOR SOLUTION | Actual shortage | 2025-04-25 | 2025-04-26 | 255774 |
| MICAFUNGIN SODIUM FOR INJECTION | 100MG | POWDER FOR SOLUTION | Actual shortage | 2024-09-16 | 2024-09-16 | 237779 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2018-10-30 | 2019-06-20 | 65888 |
| NALOXONE HYDROCHLORIDE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2023-11-17 | 2025-08-18 | 210664 |
| NALOXONE INJECTABLE | 0.4MG | SOLUTION | Resolved | 2022-12-05 | 2022-12-31 | 177165 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2017-11-30 | 2017-12-14 | 31386 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2020-12-25 | 130358 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2021-01-20 | 130361 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | Resolved | 2018-08-10 | 2019-02-20 | 57888 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-07 | 253339 |
| BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | 0.2% | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253342 |
| DORZOLAMIDE AND TIMOLOL EYE DROPS BP | 5MG 20MG | SOLUTION | Discontinued | 2024-11-01 | 2024-11-01 | 241852 |
| LATANOPROST AND TIMOLOL OPHTHALMIC SOLUTION | 5MG 50MCG | SOLUTION | Discontinued | 2024-10-01 | 2024-10-02 | 239073 |
| LATANOPROST OPHTHALMIC SOLUTION | 50MCG | SOLUTION | Discontinued | 2025-03-24 | 2025-04-02 | 253336 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 9 of 9